OTC Drug Market in India 2014, New Report Launched

OTC Drug Market in India 2014 report highlights the analysis of the drivers and explains the factors for growth of the industry. Increasing self-medicated patient population, growing confidence in OTC drugs, and change of prescription drugs to OTC drugs are the key drivers of this market. The various segments of OTC drugs such as Vitamins & Minerals, Gastrointestinal, and Cough Cold & Allergy etc. are the major reasons for the popularity of the OTC drug market.

Growing number of self-treatment patient base and their confidence in the OTC drugs is helping the Indian market to grow. Prescription drugs, after becoming OTC, present a huge opportunity for growth. OTC drugs increase the availability of different types of drugs intended for self-medication among patients, which helps in the growth of the market. The increasing disposable income of people is also helping to boost the market size.  Some challenges faced by the industry are the internal competition between large pharmaceutical companies. Another challenge is the penetration of OTC drugs in rural areas which is very low. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well.

Spanning over 85 pages, “OTC Drug Market in India 2014” report covering the Executive Summary, Macroeconomic Indicators, Market Overview, Value Chain, Drivers & Challenges, Government Initiatives, Regulations, Competitive Landscape, Recent Developments, Strategic Recommendation, Appendix. This report Covered 10 Companies - Amrutanjan Healthcare Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Lupin Ltd., Novartis India Ltd., Pfizer Ltd., P& G, Ranbaxy Laboratories Ltd., Merck Ltd Sun Pharmaceutical Industries Ltd.

Know more about this report at – http://mrr.cm/ZuD

Find all OTC Drugs Reports at: http://www.marketresearchreports.com/otc-drugs